2-naphthol has been researched along with Cutaneous T-Cell Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, X; Li, W; Wang, Y; Zhang, C; Zhang, Q | 1 |
| Gu, X; He, X; Li, W; Men, Y; Wang, Y; Zhang, C; Zhang, Q | 1 |
2 other study(ies) available for 2-naphthol and Cutaneous T-Cell Lymphoma
| Article | Year |
|---|---|
PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Disulfides; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Leukocytes, Mononuclear; Lymphoma, T-Cell, Cutaneous; Mice; Mice, Inbred NOD; Mice, SCID; Naphthols; p21-Activated Kinases; Proto-Oncogene Proteins; RNA, Small Interfering; Skin; Skin Neoplasms; Up-Regulation; Xenograft Model Antitumor Assays | 2018 |
Targeting Phosphorylation of p21-activated Kinase 1 at Thr423 Induces Cell Cycle Arrest and Apoptosis in Cutaneous T-cell Lymphoma Cells.
Topics: Adult; Aged; Antineoplastic Agents; Apoptosis; bcl-Associated Death Protein; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Disulfides; Dose-Response Relationship, Drug; Early Growth Response Protein 1; Female; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Molecular Targeted Therapy; Naphthols; p21-Activated Kinases; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Skin Neoplasms; Time Factors | 2019 |